Science Explorer Back to mapMap
Discussion
Researcher · CHRISTUS Transplant Institute · United States

Paul J. Shaughnessy

Paul J. Shaughnessy publishes mostly in Hematology, Oncology and Public Health, Environmental and Occupational Health, on topics such as Hematopoietic Stem Cell Transplantation, CAR-T cell therapy research and Acute Lymphoblastic Leukemia research.

ORCID 0000-0003-4023-3864 OpenAlex
World rank
#2,335,936
of 7,710,434 ranked researchers
Rank in United States
#695,440
of 1,627,098
Works
229
Citations
4.2k
Citations per work
18.1
h-index
26
i10-index 50Top 16% in Hematology
Paul J. Shaughnessy

What does Paul J. Shaughnessy research?

Paul J. Shaughnessy's work is mostly in Medicine (64%), Immunology and Microbiology (8%).

Health Sciences: 145 works · 63.5% of their workMedicine: 145 works · 63.5% of their workHematology: 55 works · 23.9% of their workOncology: 46 works · 20.2% of their workPublic Health, Environmental and Occupational Health: 23 works · 10.2% of their workGenetics: 12 works · 5.4% of their workEpidemiology: 9 works · 3.8% of their workEverything else: 65 works · 28.5% of their workLife Sciences: 18 works · 8.0% of their workImmunology and Microbiology: 18 works · 8.0% of their workImmunology: 18 works · 8.0% of their workTHEIR WORKPaul J.Shaughnessy229works
Life Sciences8%Health Sciences64%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine14563.5%
  2. Everything else6528.5%
    1. Immunology and Microbiology188.0%
  1. 1Hematology24% of their works
  2. 2Oncology20% of their works
  3. 3Public Health, Environmental and Occupational Health10% of their works
  4. 4Immunology8% of their works
  5. 5Genetics5% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Paul J. Shaughnessy's research?

The keywords of their largest research topics: Hematopoietic Stem Cells, Prognostic Factors, Bone Marrow Niche, Graft-versus-Host Disease, Minimal Residual Disease, CAR T Cells, Chimeric Antigen Receptor and Acute Lymphoblastic Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Hematopoietic Stem Cells1082 topics
  2. Prognostic Factors933 topics
  3. Bone Marrow Niche871 topic
  4. Graft-versus-Host Disease871 topic
  5. Minimal Residual Disease792 topics
  6. CAR T Cells731 topic
  7. Chimeric Antigen Receptor731 topic
  8. Acute Lymphoblastic Leukemia561 topic
  9. Childhood Cancer561 topic
  10. Diagnosis Criteria231 topic
  11. International Myeloma Working Group231 topic
  12. AML211 topic
  13. Acute Myeloid Leukemia211 topic
  14. Antimicrobial Agents161 topic
  15. Chronic Lymphocytic Leukemia161 topic
  16. Febrile Neutropenia161 topic
  17. Genomic Aberrations161 topic
  18. Kidney Transplantation141 topic
  19. Renal Allograft141 topic

Where does Paul J. Shaughnessy work?

Paul J. Shaughnessy's main affiliation in the publication record is CHRISTUS Transplant Institute, United States.

How many publications and citations does Paul J. Shaughnessy have?

OpenAlex counts 229 works and 4,150 citations for Paul J. Shaughnessy, an h-index of 26, ranking #2,335,936 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Paul J. Shaughnessy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.